There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Cancer Drug Coverage Parity Act of 2013

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms no less favorable than the coverage provided for anticancer medications administered by a health care provider.


Actions Overview (1)

Date
04/26/2013Introduced in House

All Actions (8)

Date
07/08/2013Referred to the Subcommittee on Health, Employment, Labor, and Pensions.
Action By: Committee on Education and the Workforce
06/03/2013Referred to the Subcommittee on Health.
Action By: Committee on Ways and Means
05/03/2013Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
04/26/2013Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
04/26/2013Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
04/26/2013Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
04/26/2013Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
04/26/2013Introduced in House
Action By: House of Representatives

Cosponsors (92)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Moore, Gwen [D-WI-4]* 04/26/2013
Rep. Pingree, Chellie [D-ME-1]* 04/26/2013
Rep. Cicilline, David N. [D-RI-1]* 04/26/2013
Rep. Capps, Lois [D-CA-24]* 04/26/2013
Rep. Grijalva, Raul M. [D-AZ-3]* 04/26/2013
Rep. Wilson, Frederica S. [D-FL-24]* 04/26/2013
Rep. Hastings, Alcee L. [D-FL-20]* 04/26/2013
Rep. King, Peter T. [R-NY-2]* 04/26/2013
Rep. Rangel, Charles B. [D-NY-13]* 04/26/2013
Rep. Larsen, Rick [D-WA-2]* 04/26/2013
Rep. McGovern, James P. [D-MA-2]* 04/26/2013
Rep. Peters, Scott H. [D-CA-52]* 04/26/2013
Rep. Wolf, Frank R. [R-VA-10]* 04/26/2013
Rep. Moran, James P. [D-VA-8]* 04/26/2013
Rep. Farr, Sam [D-CA-20]* 04/26/2013
Rep. Ellison, Keith [D-MN-5] 05/06/2013
Rep. Connolly, Gerald E. [D-VA-11] 05/06/2013
Rep. DeLauro, Rosa L. [D-CT-3] 05/06/2013
Rep. Maloney, Carolyn B. [D-NY-12] 05/06/2013
Rep. Polis, Jared [D-CO-2] 05/15/2013
Rep. Engel, Eliot L. [D-NY-16] 05/15/2013
Rep. Ryan, Tim [D-OH-13] 05/15/2013
Rep. Pastor, Ed [D-AZ-7] 05/15/2013
Rep. Schwartz, Allyson Y. [D-PA-13] 05/15/2013
Rep. Langevin, James R. [D-RI-2] 05/21/2013
Rep. Huffman, Jared [D-CA-2] 05/21/2013
Rep. Wittman, Robert J. [R-VA-1] 05/21/2013
Rep. Bonamici, Suzanne [D-OR-1] 05/21/2013
Rep. Schakowsky, Janice D. [D-IL-9] 05/23/2013
Rep. Israel, Steve [D-NY-3] 05/23/2013
Rep. Loebsack, David [D-IA-2] 06/04/2013
Rep. Braley, Bruce L. [D-IA-1] 06/11/2013
Rep. Tonko, Paul [D-NY-20] 06/11/2013
Rep. Enyart, William L. [D-IL-12] 06/11/2013
Rep. Lee, Barbara [D-CA-13] 06/11/2013
Rep. Frelinghuysen, Rodney P. [R-NJ-11] 06/11/2013
Rep. Wasserman Schultz, Debbie [D-FL-23] 06/12/2013
Rep. Carney, John C., Jr. [D-DE-At Large] 06/12/2013
Rep. Takano, Mark [D-CA-41] 06/12/2013
Rep. Titus, Dina [D-NV-1] 06/12/2013
Rep. Payne, Donald M., Jr. [D-NJ-10] 06/13/2013
Rep. Michaud, Michael H. [D-ME-2] 06/13/2013
Rep. Lofgren, Zoe [D-CA-19] 06/26/2013
Rep. Pocan, Mark [D-WI-2] 06/26/2013
Rep. Holt, Rush [D-NJ-12] 06/28/2013
Rep. Latham, Tom [R-IA-3] 07/08/2013
Rep. Lynch, Stephen F. [D-MA-8] 07/16/2013
Rep. Shea-Porter, Carol [D-NH-1] 07/16/2013
Rep. Cartwright, Matt [D-PA-17] 07/16/2013
Rep. Lipinski, Daniel [D-IL-3] 07/25/2013
Rep. Bishop, Timothy H. [D-NY-1] 07/25/2013
Rep. Schiff, Adam B. [D-CA-28] 07/25/2013
Rep. Kennedy, Joseph P., III [D-MA-4] 07/25/2013
Rep. Bonner, Jo [R-AL-1] 07/31/2013
Rep. Clay, Wm. Lacy [D-MO-1] 07/31/2013
Rep. Miller, Candice S. [R-MI-10] 08/01/2013
Rep. McCarthy, Carolyn [D-NY-4] 08/01/2013
Rep. McCollum, Betty [D-MN-4] 08/02/2013
Rep. Scott, David [D-GA-13] 09/10/2013
Rep. Esty, Elizabeth H. [D-CT-5] 09/10/2013
Rep. Kildee, Daniel T. [D-MI-5] 09/18/2013
Rep. Conyers, John, Jr. [D-MI-13] 10/10/2013
Rep. Fortenberry, Jeff [R-NE-1] 10/22/2013
Rep. Maloney, Sean Patrick [D-NY-18] 10/29/2013
Rep. Welch, Peter [D-VT-At Large] 12/09/2013
Rep. DeGette, Diana [D-CO-1] 12/12/2013
Rep. Lewis, John [D-GA-5] 01/09/2014
Rep. Johnson, Henry C. "Hank," Jr. [D-GA-4] 02/04/2014
Rep. Lance, Leonard [R-NJ-7] 02/18/2014
Rep. Matsui, Doris O. [D-CA-6] 02/25/2014
Rep. Negrete McLeod, Gloria [D-CA-35] 02/25/2014
Rep. Green, Gene [D-TX-29] 04/30/2014
Rep. Fitzpatrick, Michael G. [R-PA-8] 05/07/2014
Rep. Bishop, Sanford D., Jr. [D-GA-2] 05/07/2014
Rep. Van Hollen, Chris [D-MD-8] 05/07/2014
Rep. Davis, Susan A. [D-CA-53] 05/08/2014
Rep. Norton, Eleanor Holmes [D-DC-At Large] 05/08/2014
Rep. Swalwell, Eric [D-CA-15] 05/09/2014
Rep. Beatty, Joyce [D-OH-3] 05/20/2014
Rep. Sensenbrenner, F. James, Jr. [R-WI-5] 05/20/2014
Rep. Clark, Katherine M. [D-MA-5] 05/21/2014
Rep. Courtney, Joe [D-CT-2] 05/21/2014
Rep. Benishek, Dan [R-MI-1] 05/22/2014
Rep. Young, Don [R-AK-At Large] 05/28/2014
Rep. Delaney, John K. [D-MD-6] 05/30/2014
Rep. Tierney, John F. [D-MA-6] 05/30/2014
Rep. Eshoo, Anna G. [D-CA-18] 07/17/2014
Rep. Smith, Christopher H. [R-NJ-4] 09/09/2014
Rep. Yarmuth, John A. [D-KY-3] 09/10/2014
Rep. Miller, Jeff [R-FL-1] 09/11/2014
Rep. Blumenauer, Earl [D-OR-3] 11/14/2014
Rep. Butterfield, G. K. [D-NC-1] 11/14/2014

Committees (3)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce04/26/2013 Referred to
House Energy and Commerce Subcommittee on Health05/03/2013 Referred to
House Ways and Means04/26/2013 Referred to
House Ways and Means Subcommittee on Health06/03/2013 Referred to
House Education and the Workforce04/26/2013 Referred to
House Education and the Workforce Subcommittee on Health, Employment, Labor, and Pensions07/08/2013 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (9)


Latest Summary (1)

There is one summary for H.R.1801. View summaries

Shown Here:
Introduced in House (04/26/2013)

Cancer Drug Coverage Parity Act of 2013 - Amends the Employee Retirement Income Security Act of 1974 (ERISA), the Public Health Service Act, and the Internal Revenue Code to require a group or individual health plan providing benefits with respect to anticancer medications administered by a health care provider to provide no less favorable coverage for prescribed, patient-administered anticancer medications used to kill, slow, or prevent the growth of cancerous cells and that have been approved by the Food and Drug Administration (FDA).

Applies such requirement to medication that is prescribed based on a finding by the treating physician that the medication is: (1) medically necessary for the purpose of killing, slowing, or preventing the growth of cancerous cells in accordance with nationally accepted standards of medical practice; and (2) clinically appropriate in terms of type, frequency, extent site, and duration.

Permits such coverage to be subject to the same cost-sharing applicable to anticancer medications administered by a health care provider under the plan.

Prohibits a health plan from imposing an increase in out-of-pocket costs, reclassifying benefits with respect to anticancer medications, or applying more restrictive limitations on prescribed orally- or intravenously-administered or injected anticancer medications.

Requires a plan to provide notice to each participant and beneficiary regarding the coverage required under this Act.

Prohibits a health plan from taking specified actions to avoid the requirements of this Act.

Requires the Medicare Payment Advisory Commission to assess how closing the Medicare part D donut hole affects Medicare coverage for orally-administered anticancer medications, with a particular focus on cost and accessibility.